Keywords: لوسمی لنفوسیتی مزمن (CLL); proptosis; orbital inflammation; thyroid eye disease; Graves' ophthalmopathy; chronic lymphocytic leukemia (CLL); small lymphocytic lymphoma (SLL); lymphoproliferative disorder; orbital lymphoma;
مقالات ISI لوسمی لنفوسیتی مزمن (CLL) (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لوسمی لنفوسیتی مزمن (CLL); Chronic lymphocytic leukemia (CLL); Allogeneic transplantation; Autologous transplantation; Cellular therapy;
Keywords: لوسمی لنفوسیتی مزمن (CLL); Chronic lymphocytic leukemia (CLL); Allogeneic transplantation; Autologous transplantation; Cellular therapy;
Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group
Keywords: لوسمی لنفوسیتی مزمن (CLL); Chronic lymphocytic leukemia (CLL); Pneumococcal vaccine; Polysaccharide vaccine; Protein-conjugate vaccine; Immunogenicity;
Affecting NF-κB cell signaling pathway in chronic lymphocytic leukemia by dendrimers-based nanoparticles
Keywords: لوسمی لنفوسیتی مزمن (CLL); Chronic lymphocytic leukemia (CLL); Gene expression; Glycodendrimer, NF-κB; Signaling pathway; PPI dendrimer;
Biology and clinical relevance of noncoding sno/scaRNAs
Keywords: لوسمی لنفوسیتی مزمن (CLL); Noncoding RNA; Small Cajal body-associated RNA; Spliceosomal RNA; Small nucleolar RNA; Alternative splicing; AGO; argonaute; CLL; chronic lymphocytic leukemia (CLL); CB; Cajal body; CTD; carboxyl-terminal domain; DC; Dyskeratosis congenital; DKC1; Dyskera
Research paperQuantitative and qualitative analysis of regulatory T cells in B cell chronic lymphocytic leukemia
Keywords: لوسمی لنفوسیتی مزمن (CLL); CLL; chronic lymphocytic leukemia; Tregs; T regulatory cells; Teffs; T effector cells; NB cells; normal B cells; CLL cells; CLL B cells; Chronic lymphocytic leukemia (CLL); T regulatory cells; CLL cells; Apoptosis; Immunophenotype;
Dendrimer-based nanoparticles for potential personalized therapy in chronic lymphocytic leukemia: Targeting the BCR-signaling pathway
Keywords: لوسمی لنفوسیتی مزمن (CLL); Chronic lymphocytic leukemia (CLL); Poly(propylene imine)dendrimers (PPI); Gene expression; B-cell receptor (BCR)
Increased IL-10/IL-17 ratio is aggravated along with the prognosis of patients with chronic lymphocytic leukemia
Keywords: لوسمی لنفوسیتی مزمن (CLL); Chronic lymphocytic leukemia (CLL); Regulatory T (Treg) cells; Th17 cells; IL-10; IL-17
A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI)
Keywords: لوسمی لنفوسیتی مزمن (CLL); Chronic lymphocytic leukemia (CLL); Magnetic resonance imaging (MRI); Ultra-small superparamagnetic iron oxide (USPIO); Xenograft NSG mice model; Disease monitoring;
A case of Richter's syndrome with transformation of B-CLL to DLBCL in the mandibular condyle region
Keywords: لوسمی لنفوسیتی مزمن (CLL); Richter's syndrome; Chronic lymphocytic leukemia (CLL); Mandibular condyle; Diffuse large B-cell lymphoma (DLBCL)
Ellagic acid, a polyphenolic compound, selectively induces ROS-mediated apoptosis in cancerous B-lymphocytes of CLL patients by directly targeting mitochondria
Keywords: لوسمی لنفوسیتی مزمن (CLL); Ellagic acid; Active oxygen radicals (ROS); Apoptosis; Chronic lymphocytic leukemia (CLL); Mitochondria
Poly(ADP-ribose) polymerase inhibitor CEP-8983 synergizes with bendamustine in chronic lymphocytic leukemia cells in vitro
Keywords: لوسمی لنفوسیتی مزمن (CLL); Chronic lymphocytic leukemia (CLL); Poly(ADP-ribose) polymerase (PARP); CEP-8983; Bendamustine
Recurrent Chromosome Abnormalities Define Nonoverlapping Unique Subgroups of Tumors in Patients With Chronic Lymphocytic Leukemia and Known Karyotypic Abnormalities
Keywords: لوسمی لنفوسیتی مزمن (CLL); Chronic lymphocytic leukemia (CLL); del(13q); Chromosome banding analysis; Trisomy 12
Optimal management of older patients with chronic lymphocytic leukemia: Some facts and principles guiding therapeutic choices
Keywords: لوسمی لنفوسیتی مزمن (CLL); Chronic lymphocytic leukemia (CLL); Elderly; Old; Therapy; Chemoimmunotherapy; Clinical trials; Rituximab; Purine analogs; Fludarabine
Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 Years
Keywords: لوسمی لنفوسیتی مزمن (CLL); Chronic lymphocytic leukemia (CLL); Chemoimmunotherapy; Mitoxantroe; Nucleoside analogs
Gene expression profile of protein kinases reveals a distinctive signature in chronic lymphocytic leukemia and in vitro experiments support a role of second generation protein kinase inhibitors
Keywords: لوسمی لنفوسیتی مزمن (CLL); Protein kinases (PKs); Chronic lymphocytic leukemia (CLL); Gene expression profile; MTT assay; IGHV mutational status; PK inhibitors
JAK2 mutation in a patient with CLL with coexistent myeloproliferative neoplasm (MPN)
Keywords: لوسمی لنفوسیتی مزمن (CLL); Chronic lymphocytic leukemia (CLL); Myeloproliferative neoplasm (MPN); JAK2 mutation
Prognostic markers in chronic lymphocytic leukemia: A comprehensive review
Keywords: لوسمی لنفوسیتی مزمن (CLL); Chronic lymphocytic leukemia (CLL); Prognostic factors; Cytogenetic markers; Mutation status; ZAP70; CD38
Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early–intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab
Keywords: لوسمی لنفوسیتی مزمن (CLL); Chronic lymphocytic leukemia (CLL); Alemtuzumab; Rituximab; Complement; Cytotoxicity
CLL cell apoptosis induced by nitric oxide synthase inhibitors: Correlation with lipid solubility and NOS1 dissociation constant
Keywords: لوسمی لنفوسیتی مزمن (CLL); Chronic lymphocytic leukemia (CLL); Nitric oxide; Nitric oxide synthase type I; Apoptosis; Human
Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia
Keywords: لوسمی لنفوسیتی مزمن (CLL); Chronic lymphocytic leukemia (CLL); TCL-1; Prognostic factor; Pentostatin; Chemoimmunotherapy
Management of symptomatic, untreated chronic lymphocytic leukemia
Keywords: لوسمی لنفوسیتی مزمن (CLL); Chronic lymphocytic leukemia (CLL); Fludarabine; Rituximab; Alemtuzumab
Review of the literature on benzene exposure and leukemia subtypes
Keywords: لوسمی لنفوسیتی مزمن (CLL); Benzene; Acute myeloid leukemia (AML); Chronic myeloid leukemia (CML); Acute lymphocytic leukemia (ALL); Chronic lymphocytic leukemia (CLL); Case-control; Cohort;